| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.974 | 0.001 | 0.974 | Dipeptidyl peptidase IV inhibitor | 0.507 0.002 DBMET02430 0.204 0.003 DBMET02431 0.627 0.001 DBMET02432 0.108 0.005 DBMET02433 | ||
| 0.973 | 0.001 | 0.973 | Dipeptidyl peptidase inhibitor | 0.504 0.002 DBMET02430 0.197 0.004 DBMET02431 0.639 0.001 DBMET02432 0.121 0.006 DBMET02433 | ||
| 0.918 | 0.004 | 0.918 | Cyclophilin D inhibitor | 0.759 0.009 DBMET02430 0.593 0.029 DBMET02431 0.803 0.006 DBMET02432 0.858 0.005 DBMET02433 | ||
| 0.734 | 0.001 | 0.734 | Dipeptidyl peptidase VIII inhibitor | 0.251 0.002 DBMET02430 0.058 0.004 DBMET02431 0.322 0.002 DBMET02432 0.088 0.003 DBMET02433 | ||
| 0.606 | 0.001 | 0.606 | Dipeptidyl peptidase IX inhibitor | 0.085 0.003 DBMET02430 0.016 0.011 DBMET02431 0.096 0.003 DBMET02432 0.043 0.004 DBMET02433 | ||
| 0.565 | 0.001 | 0.565 | Dipeptidyl peptidase II inhibitor | 0.117 0.003 DBMET02430 0.039 0.015 DBMET02431 0.252 0.002 DBMET02432 0.034 0.02 DBMET02433 | ||
| 0.476 | 0.003 | 0.476 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.178 0.004 DBMET02430 0.189 0.004 DBMET02431 0.242 0.004 DBMET02432 0.04 0.012 DBMET02433 | ||
| 0.486 | 0.04 | 0.486 | Antiobesity | 0.323 0.101 DBMET02431 0.244 0.162 DBMET02432 0.306 0.112 DBMET02433 | ||
| 0.444 | 0.021 | 0.565 | Hypoglycemic | 0.266 0.067 DBMET02430 0.327 0.044 DBMET02431 0.406 0.026 DBMET02432 0.565 0.01 DBMET02433 | DBMET02433 | |
| 0.449 | 0.031 | 0.54 | Immunomodulator | 0.309 0.077 DBMET02430 0.32 0.072 DBMET02431 0.54 0.018 DBMET02432 0.526 0.02 DBMET02433 | DBMET02432 | |
| 0.363 | 0.017 | 0.458 | Platelet adhesion inhibitor | 0.315 0.029 DBMET02430 0.252 0.049 DBMET02431 0.347 0.02 DBMET02432 0.458 0.007 DBMET02433 | DBMET02433 | |
| 0.393 | 0.087 | 0.393 | Analgesic | 0.314 0.131 DBMET02432 0.244 0.188 DBMET02433 | ||
| 0.31 | 0.004 | 0.31 | Purinergic P2 antagonist | 0.253 0.005 DBMET02430 0.123 0.014 DBMET02431 0.252 0.005 DBMET02432 0.104 0.02 DBMET02433 | ||
| 0.424 | 0.125 | 0.7 | Antiinflammatory | 0.7 0.031 DBMET02433 | DBMET02433 | |
| 0.203 | 0.004 | 0.203 | Purinergic P2X antagonist | 0.125 0.006 DBMET02430 0.084 0.012 DBMET02431 0.156 0.005 DBMET02432 0.046 0.036 DBMET02433 | ||
| 0.169 | 0.004 | 0.169 | Purinergic P2X7 antagonist | 0.105 0.004 DBMET02430 0.084 0.005 DBMET02431 0.132 0.004 DBMET02432 0.051 0.014 DBMET02433 | ||
| 0.129 | 0.005 | 0.129 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.04 0.024 DBMET02430 0.052 0.016 DBMET02431 0.055 0.015 DBMET02432 | ||
| 0.198 | 0.075 | 0.198 | Insulin sensitizer | 0.188 0.086 DBMET02432 0.192 0.082 DBMET02433 | ||
| 0.128 | 0.005 | 0.128 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.028 DBMET02430 0.055 0.019 DBMET02431 0.056 0.019 DBMET02432 | ||
| 0.198 | 0.082 | 0.198 | Platelet aggregation inhibitor | 0.175 0.102 DBMET02432 0.145 0.134 DBMET02433 | ||
| 0.105 | 0.005 | 0.105 | Purinergic P2T antagonist | 0.09 0.005 DBMET02430 0.104 0.005 DBMET02431 0.089 0.005 DBMET02432 0.061 0.008 DBMET02433 | ||
| 0.098 | 0.009 | 0.098 | Vasopressin 1 antagonist | 0.042 0.017 DBMET02431 0.039 0.018 DBMET02432 | ||
| 0.096 | 0.013 | 0.096 | Antidiuretic hormone antagonist | 0.046 0.024 DBMET02431 0.038 0.029 DBMET02432 | ||
| 0.102 | 0.021 | 0.102 | MAP kinase kinase 8 inhibitor | 0.069 0.047 DBMET02432 | ||
| 0.087 | 0.015 | 0.087 | Neurokinin antagonist | 0.054 0.03 DBMET02431 0.07 0.02 DBMET02432 | ||
| 0.076 | 0.005 | 0.076 | Dipeptidyl peptidase I inhibitor | 0.031 0.02 DBMET02430 0.036 0.015 DBMET02432 | ||
| 0.08 | 0.009 | 0.08 | Neurokinin 3 antagonist | 0.045 0.031 DBMET02430 0.059 0.021 DBMET02431 0.07 0.013 DBMET02432 | ||
| 0.075 | 0.009 | 0.075 | Vasopressin 1A antagonist | 0.051 0.013 DBMET02431 0.038 0.016 DBMET02432 | ||
| 0.081 | 0.04 | 0.081 | Protein kinase B alpha inhibitor | |||
| 0.123 | 0.081 | 0.123 | Sodium channel (voltage-gated) blocker | |||
| 0.113 | 0.073 | 0.113 | Transcription factor STAT6 inhibitor | |||
| 0.086 | 0.048 | 0.086 | Glutamate receptor agonist | |||
| 0.047 | 0.018 | 0.047 | Vascular adhesion protein 1 inhibitor | |||
| 0.122 | 0.093 | 0.122 | Nav1.6 sodium channel blocker | |||
| 0.097 | 0.07 | 0.097 | Nav1.1 sodium channel blocker | |||
| 0.101 | 0.083 | 0.101 | Nav1.5 sodium channel blocker | |||
| 0.062 | 0.045 | 0.062 | 5 Hydroxytryptamine 2A agonist | |||
| 0.111 | 0.096 | 0.111 | Sodium channel blocker | |||
| 0.025 | 0.017 | 0.025 | Calcitonin gene-related peptide antagonist | |||
| 0.017 | 0.016 | 0.017 | Complement factor D inhibitor | |||
| 0.18 | 0.227 | 0.363 | Interleukin 2 agonist | 0.363 0.04 DBMET02433 | DBMET02433 | |
| 0.082 | 0.143 | 0.236 | Cell adhesion inhibitor | 0.102 0.085 DBMET02432 0.236 0.017 DBMET02433 | DBMET02433 | |
| 0.053 | 0.136 | 0.141 | Cell adhesion molecule inhibitor | 0.141 0.017 DBMET02433 | DBMET02433 | |
| 0.075 | 0.171 | 0.095 | Factor V inhibitor | 0.095 0.081 DBMET02432 | DBMET02432 | |
| 0.144 | 0.264 | 0.456 | Immunosuppressant | 0.456 0.045 DBMET02433 | DBMET02433 | |
| 0.087 | 0.219 | 0.158 | Hemostatic | 0.158 0.059 DBMET02433 | DBMET02433 | |
| 0.052 | 0.211 | 0.183 | AMP-activated protein kinase stimulant | 0.183 0.014 DBMET02433 | DBMET02433 | |
| 0.008 | 0.189 | 0.454 | 5 Hydroxytryptamine 2C agonist | 0.454 0.003 DBMET02431 | DBMET02431 | |
| 0.005 | 0.198 | 0.13 | Cholecystokinin A antagonist | 0.13 0.005 DBMET02432 | DBMET02432 | |
| 0.071 | 0.296 | 0.151 | Insulin secretagoues | 0.151 0.073 DBMET02433 | DBMET02433 | |
| 0.069 | 0.298 | 0.199 | Platelet antagonist | 0.199 0.101 DBMET02433 | DBMET02433 | |
| 0.052 | 0.286 | 0.144 | Anticoagulant | 0.144 0.086 DBMET02433 | DBMET02433 | |
| 0.009 | 0.286 | 0.314 | 5 Hydroxytryptamine agonist | 0.314 0.008 DBMET02431 | DBMET02431 | |
| 0.005 | 0.283 | 0.09 | Cholecystokinin antagonist | 0.09 0.009 DBMET02432 | DBMET02432 | |
| 0.004 | 0.284 | 0.059 | Leukotriene A4 hydrolase inhibitor | 0.059 0.016 DBMET02432 | DBMET02432 | |
| 0.011 | 0.322 | 0.189 | Selectin antagonist | 0.189 0.012 DBMET02433 | DBMET02433 | |
| 0.031 | 0.349 | 0.144 | Thrombolytic | 0.144 0.086 DBMET02433 | DBMET02433 | |
| 0.02 | 0.379 | 0.112 | Protease inhibitor | 0.086 0.079 DBMET02432 0.112 0.055 DBMET02433 | DBMET02433 | |
| 0.094 | 0.471 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.118 DBMET02431 | DBMET02431 | |
| 0.01 | 0.419 | 0.063 | Mineralocorticoid receptor antagonist | 0.063 0.018 DBMET02430 | DBMET02430 | |
| 0.003 | 0.44 | 0.042 | Cholecystokinin B antagonist | 0.042 0.013 DBMET02432 | DBMET02432 | |
| 0.077 | 0.516 | 0.306 | Apoptosis antagonist | 0.306 0.082 DBMET02433 | DBMET02433 | |
| 0.055 | 0.495 | 0.327 | Antithrombotic | 0.327 0.073 DBMET02433 | DBMET02433 | |
| 0.012 | 0.499 | 0.044 | Antibiotic Aminoglycoside-like | 0.044 0.017 DBMET02433 | DBMET02433 | |
| 0.005 | 0.52 | 0.041 | HIV-1 protease inhibitor | 0.041 0.033 DBMET02433 | DBMET02433 | |
| 0.003 | 0.565 | 0.021 | Urotensin II antagonist | 0.021 0.017 DBMET02430 | DBMET02430 | |
| 0.052 | 0.653 | 0.162 | Catenin beta inhibitor | 0.162 0.081 DBMET02431 | DBMET02431 | |
| 0.017 | 0.619 | 0.363 | Angiogenesis stimulant | 0.363 0.029 DBMET02433 | DBMET02433 | |
| 0.021 | 0.637 | 0.098 | Toll-Like receptor 4 antagonist | 0.098 0.074 DBMET02433 | DBMET02433 | |
| 0.008 | 0.626 | 0.058 | Protein 50S ribosomal subunit inhibitor | 0.058 0.033 DBMET02433 | DBMET02433 | |
| 0.071 | 0.698 | 0.257 | Peptidyltransferase inhibitor | 0.257 0.046 DBMET02433 | DBMET02433 | |
| 0.029 | 0.712 | 0.201 | Hepatoprotectant | 0.201 0.064 DBMET02433 | DBMET02433 | |
| 0.005 | 0.707 | 0.159 | HIV-1 integrase inhibitor | 0.159 0.007 DBMET02431 | DBMET02431 | |
| 0.008 | 0.784 | 0.247 | Antioxidant | 0.247 0.085 DBMET02433 | DBMET02433 | |
| 0.021 | 0.822 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.058 DBMET02433 | DBMET02433 | |
| 0.002 | 0.86 | 0.051 | Estrone sulfatase inhibitor | 0.051 0.007 DBMET02430 | DBMET02430 | |
| 0.005 | 0.894 | 0.174 | Free radical scavenger | 0.174 0.12 DBMET02433 | DBMET02433 | |
| 0.005 | 0.936 | 0.148 | Nitric oxide antagonist | 0.148 0.096 DBMET02433 | DBMET02433 | |
| 0.004 | 0.946 | 0.268 | Protein-tyrosine phosphatase inhibitor | 0.268 0.026 DBMET02430 | DBMET02430 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |